The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis

Abstract

Background:: Serotonin (5-HT) has a pleiotropic function in gastrointestinal, neurological/psychiatric and liver diseases. The aim of this review was to elucidate whether the gut-microbiota played a critical role in regulating peripheral serotonin levels. Methods:: We searched for relevant studies published in English using the PubMed database from 1993 to the present. Results: : Several studies suggested that alterations in the gut-microbiota may contribute to a modulation of serotonin signalling. The first indication regarded the changes in the composition of the commensal bacteria and the intestinal transit time caused by antibiotic treatment. The second indication regarded the changes in serotonin levels correlated to specific bacteria. The third indication regarded the fact that decreased serotonin transporter expression was associated with a shift in gut-microbiota from homeostasis to inflammatory type microbiota. Serotonin plays a key role in the regulation of visceral pain, secretion, and initiation of the peristaltic reflex; however, its altered levels are also detected in many different psychiatric disorders. Symptoms of some gastrointestinal functional disorders may be due to deregulation in central nervous system activity, dysregulation at the peripheral level (intestine), or a combination of both (brain-gut axis) by means of neuro-endocrine-immune stimuli. Moreover, several studies have demonstrated the profibrogenic role of 5-HT in the liver, showing that it works synergistically with platelet-derived growth factor in stimulating hepatic stellate cell proliferation. Conclusion:: Although the specific interaction mechanisms are still unclear, some studies have suggested that there is a correlation between the gut-microbiota, some gastrointestinal and liver diseases and the serotonin metabolism.

Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis

“…Symptoms of some gastrointestinal functional disorders may be due to deregulation of CNS activity, dysregulation at the peripheral level (intestine), or a combination of both (brain-gut axis) by means of neuro-endocrine-immune stimuli. In addition, several studies have demonstrated the profibrogenic role of serotonin in the liver, showing that it works synergistically with platelet-derived growth factor in stimulating hepatic stellate cell proliferation [237].…”

Irritable bowel syndrome and functional dyspepsia in patients with eating disorders ‐ a systematic review

“…Additionally, it was speculated that patients with diarrhoea-predominant IBS might present with higher plasma levels of serotonin due to an impaired re-uptake, while patients with constipation-predominant IBS might have lower postprandial plasma levels due to a disturbance of the serotonin release (Holtmann et al, 2017), indicating that an impaired serotonin signalling seems to be involved in the pathogenesis of IBS affecting intestinal motility. Furthermore, an association of serotonin transporter polymorphisms and psychiatric illnesses, frequent in patients with IBS, has been established (Cristina et al, 2019). Taking these results into account could help to explain why central neuromodulators such as antidepressants affecting the serotonin system are also useful to treat FGIDs (Drossman et al, 2018).…”

Tryptophan Metabolism and Gut-Brain Homeostasis

“…In rats, development of ECs begins in utero in the duodenum and reaches levels seen in adult rats by birth [83]. Interestingly, once the BBB has been established in developing animals, gut serotonin levels rise dramatically until SERT expression in intestinal epithelium increases in the postnatal period [84]. Enteric nervous tissue develops from invading vagal and sacral neural crest cells that differentiate into neurons and glia.…”